NCT Number: NCT07273448
Evaluate the postoperative survival rate and incidence of rejection in patients undergoing ABO-incompatible living donor liver transplantation; analyze the occurrence of secondary endpoint events such as postoperative vascular complications and biliary complications; and explore relevant risk factors affecting prognosis.
Interested in participating?
Request InfoAll sexes
Observational
Prospective and retrospective
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Minimum follow-up period of 1 year postoperatively.
Time frame: Within 1 year postoperatively
Time frame: Within 1 year postoperatively
Time frame: Within 1 year postoperatively
Zhi-Jun Zhu
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06921330
ABO Incompatibility, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Karabük, Karabük Province, Turkey (Türkiye)
View Trial DetailsNCT06502847
ABO Hemolytic Disease, ABO Incompatibility
Istanbul, Kucukcekmece, Turkey (Türkiye)
View Trial DetailsNCT05581745
ABO Incompatibility, Lung Transplant
Toronto, Ontario, Canada
View Trial DetailsNCT07329296
Living Donor Liver Transplantation
Rotterdam, South Holland, Netherlands
View Trial Details